- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Thoracic Aorta Abnormality in Argentina
Total 178 results
-
Hospital El CruceCompletedARDS | Ventilator-Induced Lung Injury | Mechanical Ventilation ComplicationArgentina
-
Hoffmann-La RocheCompletedCarcinoma, Non-small-cell LungArgentina
-
IgenomixRecruitingInfertility | Aneuploidy | Chromosome AbnormalityFrance, Argentina, Spain, United States, Brazil, Italy
-
IgenomixCompletedInfertility | Aneuploidy | Chromosome AbnormalityMexico, Turkey, United States, Argentina, Spain, Brazil, Italy, Peru
-
Laboratorio Elea Phoenix S.A.CompletedAdvanced Non-small Cell Lung CancerArgentina
-
TakedaCompletedCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseArgentina
-
Laboratorio Elea Phoenix S.A.Syneos HealthRecruitingNon Small Cell Lung Cancer MetastaticArgentina
-
Clinica ColonCompleted
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Brazil, Chile, Mexico
-
Centro de Educación Medica e Investigaciones Clínicas...CompletedVentilator-Induced Lung Injury | Respiratory Distress Syndrome, AdultArgentina
-
Mast Therapeutics, Inc.Worldwide Clinical Trials; Synteract, Inc.; Thywill Latam Solutions SRL; OCASA...CompletedA Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.Breast Cancer | Non-small Cell Lung Cancer | Non-Hodgkins LymphomaArgentina
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell LungArgentina, Colombia, Uruguay, Chile
-
AstraZenecaINCUNA (Scientific and Technical partner)Active, not recruitingPulmonary NodulesBrazil, Mexico, Argentina, Chile, Panama, Colombia, Costa Rica, Dominican Republic
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Argentina, India, Taiwan, Thailand, Vietnam
-
NCIC Clinical Trials GroupCompletedLung CancerCanada, Singapore, Australia, Romania, Argentina, Brazil
-
Latin American Cooperative Oncology GroupBristol-Myers SquibbCompletedLung CancerBrazil, Argentina, Chile, Colombia, Mexico
-
Fundación GECPCompletedSexual Dysfunction | Lung CancerSpain, Portugal, Colombia, Argentina, Peru
-
Windtree TherapeuticsCompletedCOVID-19 | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)United States, Argentina
-
SanofiCompletedSmall Cell Lung Cancer | Lung Cancer | Pulmonary NeoplasmsFrance, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Spain, Belgium, Mexico, Argentina, Hungary, United Kingdom, Netherlands
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom, Argentina, Japan, Switzerland
-
AstraZenecaCompletedDiagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (IDENTIFY)Non-Small Cell Lung Cancer | Stage IIIB/IVArgentina
-
Nereus Pharmaceuticals, Inc.CompletedCancerUnited States, Australia, India, Chile, Brazil, Argentina
-
Bristol-Myers SquibbRecruitingNSCLCUnited States, Argentina, Chile, France, Italy, Poland, Romania, Spain, Australia
-
AstraZenecaCompletedNon-small-cell Lung Cancer (NSCLC)Mexico, Peru, Argentina, Taiwan, India, Thailand, Colombia, Uruguay, Chile, Dominican Republic
-
SanofiRegeneron PharmaceuticalsCompletedCarcinoma | Non Small Cell LungUnited States, France, Canada, Brazil, Poland, Romania, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Bulgaria, Estonia, India, Malaysia, Singapore, Taiwan, Czech Republic, Argentina, Finland, Hungary, Korea... and more
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Bristol-Myers SquibbEli Lilly and Company; Clovis Oncology, Inc.; ExelixisWithdrawnCarcinoma, Non-small Cell Lung CancerNetherlands, Norway, Belgium, Greece, United States, Argentina, Denmark, Mexico, Poland, Romania
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, South Africa, United Kingdom, Germany, Argentina, Belgium
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungUnited States, Taiwan, Korea, Republic of, Malaysia, Turkey, France, Spain, China, Germany, Argentina
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Australia, Brazil, China, United Kingdom, Israel, Belgium, Netherlands, Argentina, Spain, Taiwan, Canada, Italy, Poland, Turkey, Sweden, Switzerland
-
SanofiMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung Cancer | Pleural MesotheliomaChile, Korea, Republic of, Japan, Poland, Spain, United States, Argentina, Australia, France, Italy, Taiwan
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
Bristol-Myers SquibbCompletedLung CancerItaly, United States, France, Russian Federation, Spain, Argentina, Belgium, Brazil, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Netherlands, Poland, Romania, Switzerland, Turkey, United Kingdom
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Recombio SLEurofarma Laboratorios S.A.; Laboratorio Elea Phoenix S.A.; Innogene Kalbiotech... and other collaboratorsUnknownNSCLC | Lung Cancer, Non-small CellBrazil, Indonesia, Argentina, Cuba, Philippines, Singapore, Thailand
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungAustria, Germany, Spain, China, Taiwan, Argentina, Australia, Belgium, Brazil, Finland, France, Hungary, India, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Russian Federation, Ukraine, United Kingdom
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
Spectrum Pharmaceuticals, IncCompletedNon-small Cell Lung CancerUnited States, Czechia, India, Brazil, Argentina, Hungary
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, Korea, Republic of, Taiwan, France, Spain, Italy, United States, Germany, Romania, Poland, Brazil, Chile
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Israel, United States, Spain, Germany, Belgium, Italy, Brazil, France, Canada, Netherlands, Turkey
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungItaly, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala